$JKHY
JACK HENRY & ASSOCIATES INC Stock $jkhy

$jkhy Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-K Financial Statement

#000077915220000064 Filed on August 25, 2020

Income Statement

Concept	2020 Q2	2019 Q2	2019 Q1
Revenue	$410.5M	$393.5M	$380.4M
YoY Change	4.33%	-5.69%	-1.12%
Cost Of Revenue	$254.8M	$240.0M	$235.6M
YoY Change	6.16%	7.35%	7.81%
Gross Profit	$155.7M	$153.5M	$144.8M
YoY Change	1.46%	-20.74%	-12.88%
Gross Profit Margin	37.93%	39.0%	38.06%
Selling, General & Admin	$49.00M	$49.13M	$44.89M
YoY Change	-0.26%	8.47%	6.28%
% of Gross Profit	31.47%	32.01%	31.01%
Research & Development	$29.90M	$24.92M	$23.44M
YoY Change	19.99%	2.11%	3.77%
% of Gross Profit	19.2%	16.24%	16.19%
Depreciation & Amortization	$43.80M	$41.40M	$40.70M
YoY Change	5.8%	4.28%	4.36%
% of Gross Profit	28.13%	26.98%	28.11%
Operating Expenses	$78.90M	$74.05M	$68.33M
YoY Change	6.55%	6.24%	5.41%
Operating Profit	$76.80M	$79.42M	$76.44M
YoY Change	-3.3%	-6.51%	-15.73%
Interest Expense	$211.0K	$407.0K	$224.0K
YoY Change	-48.16%	-45.52%	-69.48%
% of Operating Profit	0.27%	0.51%	0.29%
Other Income/Expense, Net
YoY Change
Pretax Income	$76.67M	$79.19M	$76.37M
YoY Change	-3.18%	-6.12%	-15.24%
Income Tax	$15.33M	$18.20M	$17.12M
% Of Pretax Income	19.99%	22.98%	22.42%
Net Earnings	$61.35M	$60.99M	$59.25M
YoY Change	0.58%	-10.09%	-14.23%
Net Earnings / Revenue	14.94%	15.5%	15.58%
Basic Earnings Per Share	$0.80	$0.79	$0.77
Diluted Earnings Per Share	$0.80	$0.79	$0.77
COMMON SHARES
Basic Shares Outstanding	76.62M shares	77.06M shares	77.18M shares
Diluted Shares Outstanding	76.85M shares	77.16M shares	77.29M shares

Balance Sheet

Concept	2020 Q2	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$213.3M	$93.60M	$35.40M
YoY Change	127.88%	198.09%	-38.33%
Cash & Equivalents	$213.3M	$93.63M	$35.40M
Short-Term Investments
Other Short-Term Assets	$112.1M	$148.0M	$145.1M
YoY Change	-24.26%	22.92%	18.64%
Inventory
Prepaid Expenses
Receivables	$300.9M	$310.1M	$190.8M
Other Receivables	$21.00M	$17.80M	$17.20M
Total Short-Term Assets	$669.1M	$569.4M	$388.6M
YoY Change	17.5%	20.97%	7.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$273.4M	$272.5M	$279.9M
YoY Change	0.35%	-4.58%	7.17%
Goodwill	$686.3M	$666.9M	$666.9M
YoY Change	2.91%	2.62%	2.24%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$220.6M	$134.7M	$133.6M
YoY Change	63.71%	22.16%	33.78%
Total Long-Term Assets	$1.486B	$1.343B	$1.334B
YoY Change	10.65%	5.18%	4.08%
TOTAL ASSETS
Total Short-Term Assets	$669.1M	$569.4M	$388.6M
Total Long-Term Assets	$1.486B	$1.343B	$1.334B
Total Assets	$2.428B	$2.185B	$2.003B
YoY Change	11.15%	7.47%	5.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.880M	$9.850M	$10.91M
YoY Change	0.3%	-67.56%	48.76%
Accrued Expenses	$166.7M	$120.4M	$95.96M
YoY Change	38.49%	35.6%	15.91%
Deferred Revenue	$318.2M	$339.8M	$189.0M
YoY Change	-6.35%	3.29%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.0K		$35.00M
YoY Change
Total Short-Term Liabilities	$494.8M	$470.0M	$330.9M
YoY Change	5.29%	4.89%	14.39%
LONG-TERM LIABILITIES
Long-Term Debt	$200.0K	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$68.27M	$14.29M	$14.49M
YoY Change	377.77%	11.02%	17.83%
Total Long-Term Liabilities	$383.9M	$285.9M	$246.0M
YoY Change	34.31%	9.04%	-37.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$494.8M	$470.0M	$330.9M
Total Long-Term Liabilities	$383.9M	$285.9M	$246.0M
Total Liabilities	$878.8M	$755.8M	$576.9M
YoY Change	16.27%	6.42%	-15.45%
SHAREHOLDERS EQUITY
Retained Earnings	$2.235B	$2.066B	$2.036B
YoY Change	8.19%	8.01%	13.09%
Common Stock	$1.036M	$1.035M	$1.035M
YoY Change	0.1%	0.19%	0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.182B	$1.110B	$1.077B
YoY Change	6.45%	5.2%	3.88%
Treasury Stock Shares	26.99M shares	26.51M shares	26.26M shares
Shareholders Equity	$1.550B	$1.429B	$1.426B
YoY Change
Total Liabilities & Shareholders Equity	$2.428B	$2.185B	$2.003B
YoY Change	11.15%	7.47%	5.12%

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	$61.35M	$60.99M	$59.25M
YoY Change	0.58%	-10.09%	-14.23%
Depreciation, Depletion And Amortization	$43.80M	$41.40M	$40.70M
YoY Change	5.8%	4.28%	4.36%
Cash From Operating Activities	$234.0M	$197.7M	$41.40M
YoY Change	18.36%	11.57%	-28.62%
INVESTING ACTIVITIES
Capital Expenditures	-$44.50M	-$42.70M	-$38.40M
YoY Change	4.22%	-19.28%	20.75%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$44.50M	-$42.60M	-$38.30M
YoY Change	4.46%	-19.17%	4.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-85.70M	-96.90M	6.300M
YoY Change	-11.56%	-35.57%	-129.17%
NET CHANGE
Cash From Operating Activities	234.0M	197.7M	41.40M
Cash From Investing Activities	-44.50M	-42.60M	-38.30M
Cash From Financing Activities	-85.70M	-96.90M	6.300M
Net Change In Cash	103.8M	58.20M	9.400M
YoY Change	78.35%	-324.71%	-2450.0%
FREE CASH FLOW
Cash From Operating Activities	$234.0M	$197.7M	$41.40M
Capital Expenditures	-$44.50M	-$42.70M	-$38.40M
Free Cash Flow	$278.5M	$240.4M	$79.80M
YoY Change	15.85%	4.48%	-11.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
CY2020	dei	Entity Registrant Name EntityRegistrantName	HENRY JACK & ASSOCIATES INC
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0000779152
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	103622563	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	103496026	shares
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	26992903	shares
CY2019Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	26507903	shares
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2019Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	0	USD
CY2020Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssets
CY2020Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2020Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:AssetsAbstract
CY2020Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:DebtCurrent
CY2020Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtAndCapitalLeaseObligations
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	0-14112
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	43-1128385
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	663 Highway 60, P.O. Box 807
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Monett
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	MO
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	65708
CY2020	dei	City Area Code CityAreaCode	417
CY2020	dei	Local Phone Number LocalPhoneNumber	235-6652
CY2020	dei	Security12b Title Security12bTitle	Common Stock ($0.01 par value)
CY2020	dei	Trading Symbol TradingSymbol	JKHY
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	jkhy	Auditor Attestation Flag AuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2019Q4	dei	Entity Public Float EntityPublicFloat	11058596650	USD
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	76641833	shares
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1697067000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1552691000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1470797000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	1008464000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	923030000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	853138000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	109988000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	96378000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90340000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	197988000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	185998000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	171710000	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1894000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	1316440000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	1205406000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	1113294000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	380627000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	347285000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	357503000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1137000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	876000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	575000	USD
CY2020	us-gaap	Interest Expense InterestExpense	688000	USD
CY2019	us-gaap	Interest Expense InterestExpense	926000	USD
CY2018	us-gaap	Interest Expense InterestExpense	1920000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	449000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-50000	USD
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1345000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	381076000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	347235000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	356158000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84408000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75350000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8876000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	296668000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	271885000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	365034000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.86
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.52
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.73
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76787000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77160000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77252000	shares
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.86
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.52
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.70
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76934000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77347000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77585000	shares
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	213345000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93628000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	300945000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	310080000	USD
CY2020Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	21051000	USD
CY2019Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	17817000	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	95525000	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	106466000	USD
CY2020Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	38235000	USD
CY2019Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	35102000	USD
CY2020Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2019Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	6355000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	669101000	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	569448000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273432000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	272474000	USD
CY2020Q2	us-gaap	Deferred Costs DeferredCosts	113525000	USD
CY2019Q2	us-gaap	Deferred Costs DeferredCosts	90084000	USD
CY2020Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	340466000	USD
CY2019Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	318969000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	220591000	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134743000	USD
CY2020Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	29917000	USD
CY2019Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	31514000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	686334000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	666944000	USD
CY2020Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1485941000	USD
CY2019Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1342907000	USD
CY2020Q2	us-gaap	Assets Assets	2428474000	USD
CY2019Q2	us-gaap	Assets Assets	2184829000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9880000	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9850000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	166689000	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	120360000	USD
CY2020Q2	us-gaap	Notes Payable Current NotesPayableCurrent	115000	USD
CY2019Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	318161000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	339752000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	494845000	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	469962000	USD
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	495005000	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	472029000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2235320000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2066073000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	71461000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54554000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	243998000	USD
CY2019Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	217010000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	208000	USD
CY2019Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	0	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	68274000	USD
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14290000	USD
CY2020Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	383941000	USD
CY2019Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	285854000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	878786000	USD
CY2019Q2	us-gaap	Liabilities Liabilities	755816000	USD
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	1036000	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	1035000	USD
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1181673000	USD
CY2019Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1110124000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1549688000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	1429013000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2428474000	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2184829000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1549688000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	1429013000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	1322844000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.66
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.54
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.36
CY2020	us-gaap	Profit Loss ProfitLoss	296668000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	271885000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	365034000	USD
CY2020	us-gaap	Depreciation Depreciation	52206000	USD
CY2019	us-gaap	Depreciation Depreciation	47378000	USD
CY2018	us-gaap	Depreciation Depreciation	47975000	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	119599000	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	113255000	USD
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	104011000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-24581000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-7604000	USD
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	74884000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	16883000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	12589000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	11758000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4735000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-161000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	954000	USD
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-10540000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	11777000	USD
CY2018	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-21489000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25759000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	62165000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	82663000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-47000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7526000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6922000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	19720000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	31889000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7091000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3723000	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4179000	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5108000	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4871000	USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	23656000	USD
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1255000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	510532000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	431128000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	412142000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	30376000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	19981000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	137562000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53538000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53598000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40135000	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	0	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	0	USD
CY2018	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	350000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	11130000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	127000	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	306000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	20000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2020	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	6710000	USD
CY2019	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	6049000	USD
CY2018	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	13138000	USD
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	117262000	USD
CY2019	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	111114000	USD
CY2018	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	96647000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1150000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	5000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-197906000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-190635000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-291826000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	55000000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	35000000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	125000000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	55033000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	35000000	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	175000000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	71549000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	54864000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	48986000	USD
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	127421000	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	118745000	USD
CY2018	us-gaap	Payments Of Dividends PaymentsOfDividends	105021000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	237000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	176000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3739000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13973000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7333000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9833000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9040000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7523000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-192909000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-178305000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-203641000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	119717000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	62188000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-83325000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93628000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31440000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	114765000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	213345000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93628000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31440000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">USE OF ESTIMATES</span></div><div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Risks and Uncertainties</span></div><div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The COVID-19 pandemic has adversely impacted global economic activity and has contributed to significant volatility in financial markets during 2020 (see “COVID-19 Impact and Response” in Item 1. Business and in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations).</span></div><div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These changing conditions may affect the estimates and assumptions made by management. Such estimates and assumptions affect, among other things, the valuations of the Company’s long-lived assets, goodwill, and definite-lived intangible assets. If conditions significantly deteriorate, changes in any assumptions used may result in future goodwill impairment charges that, if incurred, could have a material adverse impact on the Company’s results of operations, total assets and total equity in the period recognized. Events and changes in circumstances arising subsequent to June 30, 2020, including those resulting from the impacts of the COVID-19 pandemic, will be reflected in management’s estimates for future periods.</span></div>
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	310080000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	21609000	USD
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2020Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26993000	shares
CY2020Q2	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	2998000	shares
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1181673000	USD
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	485000	shares
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	71549000	USD
CY2019Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	26508000	shares
CY2019Q2	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	3483000	shares
CY2020	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Not Adopted at Fiscal Year End</span></div><div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December of 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which removes certain exceptions and simplifies other requirements of Topic 740 guidance. The ASU will be effective for the Company on July 1, 2021. Early adoption of the amendments is permitted, including adoption in any interim period for public business entities for periods for which financial statements have not yet been issued. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company will adopt ASU No. 2019-12 when required, or sooner as allowed, and is assessing the timing of adoption and evaluating the impact on its consolidated financial statements.</span></div><div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, which eliminates Step 2 of the goodwill impairment test that had required a hypothetical purchase price allocation. Rather, entities should apply the same impairment assessment to all reporting units and recognize an impairment loss for the amount by which a reporting unit’s carrying amount exceeds its fair value, without exceeding the total amount of goodwill allocated to that reporting unit. Entities will continue to have the option to perform a qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU No. 2017-04 will be effective prospectively for annual or interim goodwill impairment tests in fiscal years beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU No. 2017-04 on July 1, 2020 and does not expect the adoption to have a material impact on its consolidated financial statements.</span></div><div style="text-align:justify;margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected, with an allowance for credit losses valuation account that is deducted to present the net carrying value at the amount expected to be collected. The amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted. The Company is currently in the process of evaluating the impacts of adopting this standard, including the processes, systems, data and controls that will be necessary to estimate credit reserves for impacted areas. Financial assets held by the Company subject to the “expected credit loss” model prescribed by the standard include trade and other receivables and contract assets. While the Company continues to evaluate the expected impact on its consolidated financial statements and related disclosures, it currently expects the adoption of this guidance will result in an acceleration in the timing for recognition of credit losses, and may also result in an increase in the reserve for these credit losses due to the requirement to record upfront the losses that are expected over the remaining contractual lives of its financial assets. The Company adopted ASU No. 2016-13 on July 1, 2020 and does not expect the adoption to have a material impact on its consolidated financial statements.</span></div>
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1697067000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1552691000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1470797000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	300945000	USD
CY2019Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	21446000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	54293000	USD
CY2019Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	50640000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	318161000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	339752000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	71461000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54554000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	259887000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	265946000	USD
CY2018	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	269593000	USD
CY2020Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4204569000	USD
CY2020Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.28	Rate
CY2020Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2020Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.19	Rate
CY2020Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	271010000	USD
CY2019Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	231273000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	117763000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	110894000	USD
CY2018	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	94337000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63948000	USD
CY2020Q2	jkhy	Finance Lease Right Of Use Asset Net FinanceLeaseRightOfUseAssetNet	318000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	68309000	USD
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11712000	USD
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56597000	USD
CY2020Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	323000	USD
CY2020Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	115000	USD
CY2020Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	208000	USD
CY2020Q2	jkhy	Accumulated Amortization Operating Lease Rightofuseasset AccumulatedAmortizationOperatingLeaseRightofuseasset	13719000	USD
CY2020Q2	jkhy	Accumulated Amortization Finance Lease Right Of Use Asset AccumulatedAmortizationFinanceLeaseRightOfUseAsset	38000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	16029000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	41000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	4017000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	14348000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4212000	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	33000	USD
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P88M
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0276	Rate
CY2020Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P33M
CY2020Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0242	Rate
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13444000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	12447000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10790000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8635000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5864000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	24369000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	75549000	USD
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7240000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	68309000	USD
CY2020	jkhy	Lease Payments Related To Options To Extend Lease Terms LeasePaymentsRelatedToOptionsToExtendLeaseTerms	5464000	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	15559000	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	13539000	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	11860000	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	10169000	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8835000	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	11671000	USD
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	71633000	USD
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	15196000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	10835000	USD
CY2020Q2	us-gaap	Land Land	22885000	USD
CY2019Q2	us-gaap	Land Land	23243000	USD
CY2020Q2	us-gaap	Land Improvements LandImprovements	23765000	USD
CY2019Q2	us-gaap	Land Improvements LandImprovements	25209000	USD
CY2020Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	146193000	USD
CY2019Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	147220000	USD
CY2020Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	56106000	USD
CY2019Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	48478000	USD
CY2020Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	388413000	USD
CY2019Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	365101000	USD
CY2020Q2	us-gaap	Flight Equipment Gross FlightEquipmentGross	39824000	USD
CY2019Q2	us-gaap	Flight Equipment Gross FlightEquipmentGross	39293000	USD
CY2020Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	279000	USD
CY2019Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	12411000	USD
CY2020Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	355000	USD
CY2019Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	USD
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	677820000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	660955000	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	404388000	USD
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	388481000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273432000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	272474000	USD
CY2020	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	44000	USD
CY2019	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	14315000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2019Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	6355000	USD
CY2020Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	17014000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	119599000	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	113255000	USD
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	104011000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	101581000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	80782000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	60269000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	41403000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	22553000	USD
CY2020Q2	us-gaap	Notes Payable Current NotesPayableCurrent	115000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	208000	USD
CY2019Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020	us-gaap	Interest Paid InterestPaid	475000	USD
CY2019	us-gaap	Interest Paid InterestPaid	691000	USD
CY2018	us-gaap	Interest Paid InterestPaid	1747000	USD
CY2020	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	0	USD
CY2019	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	2673000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	46137000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	54800000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	56060000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13690000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12946000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9948000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	21130000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4177000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-80509000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3451000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3427000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	5625000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84408000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75350000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8876000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	14469000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13450000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	14096000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	14325000	USD
CY2020Q2	jkhy	Deferred Tax Assets Leasing Liability DeferredTaxAssetsLeasingLiability	17122000	USD
CY2019Q2	jkhy	Deferred Tax Assets Leasing Liability DeferredTaxAssetsLeasingLiability	0	USD
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3786000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2713000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2327000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	851000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51800000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31339000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	473000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	415000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	51327000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	30924000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	39619000	USD
CY2019Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	31846000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	166343000	USD
CY2019Q2	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	154633000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	73331000	USD
CY2019Q2	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	61455000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	16032000	USD
CY2019Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	295325000	USD
CY2019Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	247934000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	243998000	USD
CY2019Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	217010000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	Rate
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.281	Rate
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036	Rate
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029	Rate
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.024	Rate
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.025	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.020	Rate
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0	Rate
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.014	Rate
CY2020	jkhy	Deferredtaxadjustmentsresultingfrom Tax Cutsand Jobs Actratereconciliation DeferredtaxadjustmentsresultingfromTaxCutsandJobsActratereconciliation	0	Rate
CY2019	jkhy	Deferredtaxadjustmentsresultingfrom Tax Cutsand Jobs Actratereconciliation DeferredtaxadjustmentsresultingfromTaxCutsandJobsActratereconciliation	0	Rate
CY2018	jkhy	Deferredtaxadjustmentsresultingfrom Tax Cutsand Jobs Actratereconciliation DeferredtaxadjustmentsresultingfromTaxCutsandJobsActratereconciliation	0.300	Rate
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.001	Rate
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.014	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.008	Rate
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	Rate
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.009	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007	Rate
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.221	Rate
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.217	Rate
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.025	Rate
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	Rate
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.28	Rate
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	473000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	473000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	415000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	63692000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	62005000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	60382000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10112000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	9434000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10495000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	9892000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1565000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1514000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	38000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	128000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	165000	USD
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10227000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1135000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	40000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	562000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	531000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	43000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	25000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	876000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10495000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1451000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	867000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	192000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2893000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10112000	USD
CY2020	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	The Company sells its products to banks, credit unions, and financial institutions throughout the United States and generally does not require collateral. All billings to customers are due 30 days from date of billing. Reserves (which are insignificant at June 30, 2020 and 2019) are maintained for potential credit losses. Customer-related risks are moderated through the inclusion of credit mitigation clauses in the Company's contracts and through the monitoring of timely payments.
CY2020	us-gaap	Concentration Risk Supplier ConcentrationRiskSupplier	In addition, some of the Company’s key solutions are dependent on technology manufactured by IBM Corporation and Microsoft. Termination of the Company’s relationship with either IBM or Microsoft could have a negative impact on the operations of the Company.
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	16883000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	12589000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	11758000	USD
CY2020	us-gaap	Restricted Stock Expense RestrictedStockExpense	15148000	USD
CY2019	us-gaap	Restricted Stock Expense RestrictedStockExpense	10828000	USD
CY2018	us-gaap	Restricted Stock Expense RestrictedStockExpense	10256000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	340000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6191000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3274000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	11248000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	34645000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	17951000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	296668000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	271885000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	365034000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76787000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77160000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77252000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	147000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	187000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	333000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76934000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77347000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77585000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.86
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.52
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.73
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.86
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.52
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.70
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41000	shares
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	Rate
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.05	Rate
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	5000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	197988000	USD
CY2020	jkhy	Defined Contribution Plan Age Requirement DefinedContributionPlanAgeRequirement	18
CY2020	jkhy	Defined Contribution Plan Employment Length Requirement DefinedContributionPlanEmploymentLengthRequirement	P6M
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	25155000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	21003000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	18821000	USD
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2020	jkhy	Reclassificationof Revenue Between Reportable Segments ReclassificationofRevenueBetweenReportableSegments	2614000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1697067000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	1008464000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	109988000	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	1316440000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	380627000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	449000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	381076000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1552691000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	923030000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	96378000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	185998000	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	1205406000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	347285000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-50000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	347235000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1470797000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	853138000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90340000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	171710000	USD
CY2018	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1894000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	1113294000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	357503000	USD
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1345000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	356158000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	438005000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	419119000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	429406000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	410537000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1697067000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	245791000	USD
CY2019Q4	us-gaap	Cost Of Revenue CostOfRevenue	249267000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	258571000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	254835000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	1008464000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24591000	USD
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27187000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28308000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29902000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	109988000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49436000	USD
CY2019Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48961000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50589000	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49002000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	197988000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	319818000	USD
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	325415000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	337468000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	333739000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	1316440000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	118187000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	93704000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	91938000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	76798000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	380627000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	508000	USD
CY2019Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	346000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	197000	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	86000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1137000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	156000	USD
CY2019Q4	us-gaap	Interest Expense InterestExpense	156000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	165000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	211000	USD
CY2020	us-gaap	Interest Expense InterestExpense	688000	USD
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	352000	USD
CY2019Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	190000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	32000	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-125000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	449000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	118539000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	93894000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	91970000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	76673000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	381076000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29169000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21796000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18115000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15328000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84408000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	89370000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	72098000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	73855000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	61345000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	296668000	USD
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.96
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.86
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76972000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76879000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76683000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76615000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76787000	shares
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.94
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.86
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77067000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76935000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76884000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76849000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76934000	shares
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	392543000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	386275000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	380364000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	393509000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1552691000	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	220112000	USD
CY2018Q4	us-gaap	Cost Of Revenue CostOfRevenue	227284000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	235594000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	923030000	USD
CY2018Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46797000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44887000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49131000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	185998000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	240040000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24026000	USD
CY2018Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23990000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23442000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24920000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	96378000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	45183000	USD
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	289321000	USD
CY2018Q4	us-gaap	Costs And Expenses CostsAndExpenses	298071000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	303923000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	314091000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	1205406000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	103222000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	88204000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	76441000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	79418000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	347285000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	291000	USD
CY2018Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	252000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	155000	USD
CY2019Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	178000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	876000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	147000	USD
CY2018Q4	us-gaap	Interest Expense InterestExpense	148000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	224000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	407000	USD
CY2019	us-gaap	Interest Expense InterestExpense	926000	USD
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-229000	USD
CY2018Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	144000	USD
CY2018Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	104000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-69000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	68089000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-50000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	76372000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	59252000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	103366000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	88308000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	79189000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	347235000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19815000	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20219000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17120000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18196000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75350000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	83551000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	60993000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	271885000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.52
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77188000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77216000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77177000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77060000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77160000	shares
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.52
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77537000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77409000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77347000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77157000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77286000	shares

Files In Submission

Name	View Source	Status
0000779152-20-000064-index-headers.html	Edgar Link	pending
0000779152-20-000064-index.html	Edgar Link	pending
0000779152-20-000064.txt	Edgar Link	pending
0000779152-20-000064-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
jkhy-20200630.htm	Edgar Link	pending
jkhy-20200630.xsd	Edgar Link	pending
jkhy-20200630xex211.htm	Edgar Link	pending
jkhy-20200630xex231.htm	Edgar Link	pending
jkhy-20200630xex311.htm	Edgar Link	pending
jkhy-20200630xex312.htm	Edgar Link	pending
jkhy-20200630xex321.htm	Edgar Link	pending
jkhy-20200630xex322.htm	Edgar Link	pending
jkhy-20200630xex41.htm	Edgar Link	pending
jkhy-20200630_cal.xml	Edgar Link	unprocessable
jkhy-20200630_def.xml	Edgar Link	unprocessable
jkhy-20200630_g1.jpg	Edgar Link	pending
jkhy-20200630_htm.xml	Edgar Link	completed
jkhy-20200630_lab.xml	Edgar Link	unprocessable
jkhy-20200630_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JKHY
JACK HENRY & ASSOCIATES INC Stock $jkhy

2020 Q2 Form 10-K Financial Statement

#000077915220000064 Filed on August 25, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKHY JACK HENRY & ASSOCIATES INC Stock $jkhy

2020 Q2 Form 10-K Financial Statement

#000077915220000064 Filed on August 25, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKHY
JACK HENRY & ASSOCIATES INC Stock $jkhy